Complement C3 is a novel modulator of the anti-factor VIII immune response.
Rayes, Julie; Ing, Mathieu; Delignat, Sandrine; Peyron, Ivan; Gilardin, Laurent; Vogel, Carl-Wilhelm; Fritzinger, David C; Frémeaux-Bacchi, Véronique; Kaveri, Srinivas V; Roumenina, Lubka T; Lacroix-Desmazes, Sébastien.
; 103(2): 351-360, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29146705
Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII.
Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A.
Immunoprotective effect of von Willebrand factor towards therapeutic factor VIII in experimental haemophilia A.
Predictive immunogenicity of Refacto AF.
A factor VIII-nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation.
Salmonella O48 Serum Resistance is Connected with the Elongation of the Lipopolysaccharide O-Antigen Containing Sialic Acid.
T cell-independent restimulation of FVIII-specific murine memory B cells is facilitated by dendritic cells together with toll-like receptor 7 agonist.
The p110Î´ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.
Systemic C3 modulates CD8+ T cell contraction after Listeria monocytogenes infection.
Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model.